- 2-Methoxyestradiol
-
2-Methoxyestradiol Systematic (IUPAC) name (8R,9S,13S,14S,17S)-2-methoxy-
13-methyl-6,7,8,9,11,12,14,15,16,17-
decahydrocyclopenta[a]phenanthrene-3,17-diolClinical data Pregnancy cat. ? Legal status ? Identifiers CAS number 362-07-2 ATC code ? PubChem CID 66414 ChemSpider 59788 UNII 6I2QW73SR5 ChEBI CHEBI:28955 ChEMBL CHEMBL299613 Chemical data Formula C19H26O3 Mol. mass 302.408 g/mol SMILES eMolecules & PubChem (what is this?) (verify) 2-Methoxyestradiol (2ME2) is a drug that prevents the formation of new blood vessels that tumors need in order to grow (angiogenesis). It is derived from estrogen, although it binds poorly to known estrogen receptors, and belongs to the family of drugs called angiogenesis inhibitors. It has undergone Phase 1 clinical trials against breast cancers. Preclinical models also suggest that 2ME2 could also be effective against inflammatory diseases such as rheumatoid arthritis. The CAS name for 2ME2 is (17 beta)-2-methoxyestra-1,3,5(10)-triene-3,17-diol. It also acts as a vasodilator. Several studies have been conducted showing 2ME2 is a microtubule-inhibitor and effective against prostate cancer in rodents.
External links
- Chemical Information and Structure from the Comparative Toxicogenomics Database
- Phase 1 trials
- EntreMed's Product Information Site
This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.